Abstract: Provided are humanized anti-CD40 antibodies and antigen-binding fragments and methods for treating disease characterized by expression of CD40 antigen.
Type:
Grant
Filed:
May 26, 2006
Date of Patent:
November 6, 2012
Assignee:
Seattle Genetics, Inc.
Inventors:
Leonard G. Presta, Lori Y. O'Connell, Svetlana O. Doronina
Abstract: This invention relates to CD30 binding agents and methods of using such binding agents for treating disease characterized by expression of CD30 antigen.